INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 3 analysts with an average price target of $5. This is a potential upside of $3.53 (240.14%) from yesterday's end of day stock price of $1.47.

Inovio Pharmaceuticals's activity chart (see below) currently has 152 price targets and 148 ratings on display. The stock rating distribution of INO is 37.5% BUY and 62.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.34% with an average time for these price targets to be met of 420.67 days.

Highest price target for INO is $6, Lowest price target is $3, average price target is $5.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER. First documented stock forecast 17-Mar-2014.

Currently out of the existing stock ratings of INO, 3 are a BUY (37.5%), 5 are a HOLD (62.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 06-Sep-2023

$5

$3.53 (240.14%)

$2.5

10 days ago
(01-Nov-2026)

7/17 (41.18%)

$4.4 (733.33%)

643

Hold Since 28-Dec-2021

$3

$1.53 (104.08%)

$4.8

2 months 30 days ago
(12-Aug-2026)

1/3 (33.33%)

$2.1 (233.33%)

6

Buy Since 10-Feb-2021

$13

$11.53 (784.35%)

$33

1 years 2 months 23 days ago
(19-Aug-2025)

4/7 (57.14%)

$11.15 (602.70%)

240

Buy Since 12-Aug-2024

$15

1 years 5 months 28 days ago
(14-May-2025)

0/2 (0%)

$10.92 (267.65%)

Show more analysts

Please expand the browser size to see the chart

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 421 days for the stock forecasts to be reached, with an average price target met ratio of 65.34%.

Which analyst most recently updated their price target on INO (Inovio Pharmaceuticals)?

Edward Tenthoff

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Edward Tenthoff works at PIPER SANDLER and has 8 price targets and 7 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Aydin Huseynov with the highest potential upside of $178.53

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Stephen Willey with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?